DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Why Novartis and Regeneron Care About This Tiny Biotech Stock

Ophthotech's Fovista may tip the scale in favor of either Novartis' Lucentis or Regeneron's Eylea.

Biotech: And Yet We've Just Begun...

Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences

Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog

Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analys

Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog

3 Stocks Moving The Drugs Industry Upward

3 Stocks Reiterated As A Buy: VZ, MRK, REGN

3 Crashing Stocks: Is 1 a Buy?

Here are three stocks that have gotten crushed lately. Are any of them worth buying?

Regeneron Plunges In What Barron's Calls A Significant Disappointment: My Analysis

Alnylam Pharmaceuticals, Inc. Has This Ratio Right

Alnylam's third-quarter earnings call was all about the pipeline data.